维普期刊资源整合服务平台（V6.5）

704篇 您的检索式：作者名="JIALAL"

选中清除导出查看参考文献查看引证文献引用追踪共36页首页上一页第1页下一页末页 /36 跳转

	题名	作者	年代	出处	被引量
1	Management of diabetic dyslipidemia: An update显示文摘Diabetic dyslipidemia is a cluster of lipoprotein abnormalities characterized by increased triglyceride level, decreased high-density lipoprotein-cholesterol levels and increase in small dense low-density lipoprotein(LDL) particles. It is extremely common in type 2 diabetes(T2DM) affecting around 70 % of patients.Diabetic is a significant risk factor for atherosclerotic cardiovascular disease(ASCVD) which is the most common cause of death in the United States and LDL-cholesterol is the number 1 predictor of ASCVD events in T2DM. The purpose of this review is to discuss the pathophysiology and treatment of diabetic dyslipidemia. In this review, we have discussed both nonpharmacological and pharmacological treatment modalities including major treatment trials which have impacted the cardiovascular outcomes in patients with diabetes. Statin therapy is the mainstay of treatment to reduce ASCVD by decreasing LDL-C by 30%-49% or at least 50% depending on risk level. Attractive adjunctive therapies include Ezetimibe which is more cost effective and PCSK9 inhibitors which display potent LDL-cholesterol lowering and ASCVD event reduction. For severe hypertriglyceridemia, to avert the risk of pancreatitis, both fish oil and fenofibrate in concert with diet is the best strategy.	Ishwarlal Jialal Gurdeep Singh	2019	World Journal of Diabetes2019，10，5：	4
2	Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role显示文摘	Senthil Kumar Venugopal Sridevi Devaraj Ishwarlal Jialal	2005	Current Opinion in Nephrology and Hypertension2005，，1：	3
3	C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells: Implications for the Metabolic Syndrome and Atherothrombosis显示文摘	Sridevi Devaraj Dan Yan Xu Ishwarlal Jialal	2003	Circulation: Journal of the American Heart Association2003，，3：	2
4	C-Reactive Protein Polarizes Human Macrophages to an M1 Phenotype and Inhibits Transformation to the M2 Phenotype显示文摘	Sridevi Devaraj Ishwarlal Jialal	2011	Arteriosclerosis, Thrombosis, and Vascular Biology2011，，6：	2
5	Reactive protein increase plasm inogen activator inhibitorl expression and activity in human a orticendo the lialcells:implications for the metabolic syndrome and a therothrombosis显示文摘	Devaraj S Xu DY Jialall C	2003	Circulation2003，107，3：	1
6	Effects of increasing does of alpha-tocopherol in providing protection of low-density liporprotein from oxidation显示文摘	Fuller CJ Huet BA Jialal I	1998	Am J Cardiol1998，1581，：	1
7	Inflammation and atherosclerosis:The value of the high-sensitivity C-reactive protein assay as a risk marker显示文摘	Jialal I Devaraj S	2001	Am J Clin Pathol2001，，：	1
8	Inflammation and atherosclerosis:the value of the highsensitive creative protein assay as a risk marker显示文摘	Jialal I Devaraj S	2001	Am J Cli Pathol2001，，：	1
9	Direct demonstration of an antiinflammatory effect of Simvastatin in subjects with the Metabol- ic syndrome显示文摘	DEVARAJ S CHAN E JIALAL I	2006	Journal of Clinical Endocrinology & Metabolism2006，91，11：	1
10	Diabetes is a proinflammatory state : a translational perspective 显示文摘	Devaraj S Dasu MR Jialal I	2010	Expert Rev Endoerinol Metab2010，5，1：	1
11	Diabetes is a proinflammatory state:a translational perspective显示文摘	Devaraj S Dasu MR Jialal I	2010	Expert Rev Endocrinol Metab2010，5，1：	1
12	Oxidative stress,inflammation,and diabetic vasculopathies:the role of alpha tocopherol therapy显示文摘	Jialal I Devaraj S Venugopal SK	2002	Free Radic Res2002，36，12：	1
13	C-reactive protein increases plasminogen activator inhibitor-1 exptession and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis显示文摘	Devaraj S Xu DY Jialal I	2003	Cir culation2003，107，4：	1
14	C-reactive protein risk marker or mediator in A therothrombosis 显示文摘	Jialal I Devaraj S Venugopal SK	2004	Hypertension2004，44，：	1
15	C-reactive protein increases plasminogen activator inhibitor-lexpression and activity inhuman aortic endothelialcells:implications for the metabolic syndrome and atherothrombosis显示文摘	Devaraj S Xu DY Jialal I	2003	Circulation2003，107，3：	1
16	C-reactive protein decreases prostacyclin release from human aortic endothelial cells显示文摘	Venugopal SK Devaraj S Jialal I	2003	Circulation2003，108，14：	1
17	Inflammation and atherosclerosis:the value of the high-sensitivity C-reactive protein assay as a risk marker显示文摘	Jialal I Devaraj S	2001	Am J Clin Pathol2001，116，1：	1
18	C-reactive protein increases plasminogen activator inhibitor-1 expression and activity inhuman aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis显示文摘	Devaraj S Xu DY Jialal I	2003	Circulation2003，107，：	1
19	Candesartan inhibits Toll-like receptor expression and activity hoth in vitro and in vivo 显示文摘	Dasu MR Riosvelasco AC Jialal I	2009	Atherosclerosis2009，202，1：	1
20	Toll- like receptor status in obesity and metabolic syndrome: A Translational Perspective 显示文摘	Jialal I Kaur H Devaraj S	2014	J Clin Endocrinol Metab2014，99，1：	1

返回顶部每页显示：

共36页首页上一页第1页下一页末页 /36 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示